Screener
MiniMed Group MMED International — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by MiniMed Group in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: MiniMed Group’s 10-Q, filed April 17, 2026.
- Filed
- Apr 17, 2026, 4:29 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-025777
FAQ
- What is MiniMed Group's international — net sales?
- MiniMed Group (MMED) reported international — net sales of $548M in Q1 2026.
- How has MiniMed Group's international — net sales changed year-over-year?
- MiniMed Group's international — net sales increased by 20.2% year-over-year, from $456M to $548M.
- What does international — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and diabetes management solutions in geographic regions outside of the company's primary domestic market. It reflects the company's global market penetration, international demand for its insulin pump and glucose monitoring technologies, and the effectiveness of its overseas distribution networks. Tracking this figure helps investors assess the company's geographic diversification and its ability to capture growth opportunities in non-domestic healthcare markets.
Ask your AI about MiniMed Group's international — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude